First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - SUGARMAN MEDICAL GROUP LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: SUGARMAN MEDICAL GROUP LIMITED, CHEVRON HOUSE, 346 LONG LANE, HILLINGDON, MIDDLESEX, UB10 9PF. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2018. The company was incorporated on 20 July 2006.

The accounts next due date is 30 September 2020. There are no mortgages.

The above was based on public record information as at 22 October 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 05882566
Date Incorporated: 20 July 2006
Date Latest Accounts: 31 December 2018
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: PRIME TIME JF LIMITED, PIMCO 2525 LIMITED
Registered Number: 05882566
Annual Return: 20 July 2015
Registered Office: CHEVRON HOUSE, 346 LONG LANE, HILLINGDON, MIDDLESEX, UB10 9PF
SIC Code and Operations: 78200
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

SUGARMAN MEDICAL GROUP LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 1 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
05719688 SUGARMAN MEDICAL LIMITED Active
03616912 SUGARMAN MIND LIMITED Active
09534892 SUGARMAN PE & SEN LIMITED Active
13005871 SUGARMAN PRODUCTS LTD Active
09962530 SUGARMAN PROPERTY INVESTMENTS LIMITED Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd